Literature DB >> 31678366

Biological depletion of neutrophils attenuates pro-inflammatory markers and the development of the psoriatic phenotype in a murine model of psoriasis.

George Han1, Annika Havnaer2, Hiu Ham Lee3, Dylan J Carmichael3, Luis R Martinez4.   

Abstract

Although neutrophils are considered a histologic hallmark of psoriasis, their pathophysiologic role in psoriasis remains unclear. We characterized the effects of neutrophil depletion via injection of monoclonal antibody 1A8 on the development of imiquimod (IMQ)-induced psoriatic lesions in a murine model. Lesions were followed with photographs and histologic analysis, revealing reduced psoriasiform scale and epidermal hyperplasia in neutrophil-depleted. ELISA and flow cytometry were used to determine relative levels of cytokines and immune cells. Compared to controls, IMQ-treated neutropenic mice had significantly lower levels of macrophages in tissue samples (P < .05) and displayed significantly lower numbers of CD4+ T-cells (P < .05). Neutropenic animals exhibited lower levels of TNF-α, IFN-γ, and IL-1β than controls (P < .05). These results show that neutropenia reduces the development of psoriasiform skin lesions and substantially decreases infiltration of pro-inflammatory cytokines and immune cells to IMQ-induced cutaneous lesions, suggesting an active role of neutrophils in maintaining inflammation in psoriasis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytokines; Imiquimod; Inflammation; Macrophages; Neutrophils; Psoriasis

Mesh:

Substances:

Year:  2019        PMID: 31678366      PMCID: PMC8043213          DOI: 10.1016/j.clim.2019.108294

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  34 in total

Review 1.  Neutrophils in the activation and regulation of innate and adaptive immunity.

Authors:  Alberto Mantovani; Marco A Cassatella; Claudio Costantini; Sébastien Jaillon
Journal:  Nat Rev Immunol       Date:  2011-07-25       Impact factor: 53.106

2.  Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis.

Authors:  Andrew M Lin; Cory J Rubin; Ritika Khandpur; Jennifer Y Wang; MaryBeth Riblett; Srilakshmi Yalavarthi; Eneida C Villanueva; Parth Shah; Mariana J Kaplan; Allen T Bruce
Journal:  J Immunol       Date:  2011-05-23       Impact factor: 5.422

3.  Cytokines in skin lesions of psoriasis.

Authors:  A J Gearing; N J Fincham; C R Bird; M Wadhwa; A Meager; J E Cartwright; R D Camp
Journal:  Cytokine       Date:  1990-01       Impact factor: 3.861

Review 4.  Cytokines in psoriasis.

Authors:  Jaymie Baliwag; Drew H Barnes; Andrew Johnston
Journal:  Cytokine       Date:  2015-01-10       Impact factor: 3.861

5.  IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway.

Authors:  Kyung-Ah Cho; Jee Won Suh; Kyung Ho Lee; Jihee Lee Kang; So-Youn Woo
Journal:  Int Immunol       Date:  2011-12-29       Impact factor: 4.823

6.  The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients.

Authors:  L M Austin; M Ozawa; T Kikuchi; I B Walters; J G Krueger
Journal:  J Invest Dermatol       Date:  1999-11       Impact factor: 8.551

7.  Risk of myocardial infarction in patients with psoriasis.

Authors:  Joel M Gelfand; Andrea L Neimann; Daniel B Shin; Xingmei Wang; David J Margolis; Andrea B Troxel
Journal:  JAMA       Date:  2006-10-11       Impact factor: 56.272

Review 8.  Cellular sources of IL-17 in psoriasis: a paradigm shift?

Authors:  Romy R M C Keijsers; Irma Joosten; Piet E J van Erp; Hans J P M Koenen; Peter C M van de Kerkhof
Journal:  Exp Dermatol       Date:  2014-11       Impact factor: 3.960

9.  Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice.

Authors:  Jean M Daley; Alan A Thomay; Michael D Connolly; Jonathan S Reichner; Jorge E Albina
Journal:  J Leukoc Biol       Date:  2007-09-20       Impact factor: 4.962

Review 10.  The IL-23/Th17 axis in the immunopathogenesis of psoriasis.

Authors:  Antonella Di Cesare; Paola Di Meglio; Frank O Nestle
Journal:  J Invest Dermatol       Date:  2009-03-26       Impact factor: 8.551

View more
  5 in total

Review 1.  Chronic Inflammation in Non-Healing Skin Wounds and Promising Natural Bioactive Compounds Treatment.

Authors:  Priscila Schilrreff; Ulrike Alexiev
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

2.  Aloperine Ameliorates IMQ-Induced Psoriasis by Attenuating Th17 Differentiation and Facilitating Their Conversion to Treg.

Authors:  Hai-Feng Zhou; Fa-Xi Wang; Fei Sun; Xin Liu; Shan-Jie Rong; Jia-Hui Luo; Tian-Tian Yue; Jun Xiao; Chun-Liang Yang; Wan-Ying Lu; Xi Luo; Qing Zhou; He Zhu; Ping Yang; Fei Xiong; Qi-Lin Yu; Shu Zhang; Cong-Yi Wang
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

3.  The endoribonuclease N4BP1 prevents psoriasis by controlling both keratinocytes proliferation and neutrophil infiltration.

Authors:  Chenliang Gou; Wenkai Ni; Panpan Ma; Fengbo Zhao; Zhou Wang; Rong Sun; Yingcheng Wu; Yuanyuan Wu; Miaomiao Chen; Hao Chen; Jie Zhang; Yu Shen; Mingbing Xiao; Cuihua Lu; Renfang Mao; Yihui Fan
Journal:  Cell Death Dis       Date:  2021-05-14       Impact factor: 8.469

Review 4.  Regulatory Roles of Estrogens in Psoriasis.

Authors:  Akimasa Adachi; Tetsuya Honda
Journal:  J Clin Med       Date:  2022-08-20       Impact factor: 4.964

Review 5.  Immunology of Acute and Chronic Wound Healing.

Authors:  Kamila Raziyeva; Yevgeniy Kim; Zharylkasyn Zharkinbekov; Kuat Kassymbek; Shiro Jimi; Arman Saparov
Journal:  Biomolecules       Date:  2021-05-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.